Markov modeling, microsimulation, and discrete event simulation for disease progression
A set of quantitative modeling techniques used to simulate the progression of disease and its associated costs and outcomes over time for economic evaluation and policy decision-making in healthcare.
These skills enable organizations to conduct rigorous cost-effectiveness analyses, support regulatory submissions, and optimize healthcare resource allocation by providing robust, evidence-based predictions of clinical and economic outcomes.
1Careers
1Categories
9.0 Avg Demand
15%
Avg AI Risk
How to Learn Markov modeling, microsimulation, and discrete event simulation for disease progression
1. Master the core concepts of health states, transitions, cycles, and discounting. 2. Understand the fundamental differences between a cohort-based Markov model, an individual-level microsimulation, and a discrete event simulation (DES) with queues and resources. 3. Learn the basic syntax and logic of a dedicated modeling language like R (with the `hesim` or `mstate` packages) or Python (with `simmer`).
1. Move from static to dynamic models by incorporating time-varying transition probabilities, patient heterogeneity (e.g., via individual characteristics in microsimulation), and competing risks. 2. Focus on calibration (fitting model outputs to observed data) and validation (checking against an external dataset). Common mistake: Ignoring the computational intensity of large microsimulations and failing to optimize code. 3. Practice constructing a complete cost-utility analysis comparing two interventions, producing an incremental cost-effectiveness ratio (ICER).
1. Design and defend complex, multi-model hybrid frameworks (e.g., a DES for hospital operations feeding into a Markov cohort model for long-term outcomes). 2. Master probabilistic sensitivity analysis (PSA) and value of information (VOI) analysis to quantify decision uncertainty and guide future research. 3. Align model architecture and parameters with specific regulatory agency (e.g., NICE, PBAC) submission guidelines and lead model validation workshops with clinical key opinion leaders.
Practice Projects
Beginner
Project
Build a 3-State Markov Cohort Model in R
Scenario
Model a chronic disease (e.g., Type 2 Diabetes) with three health states: 'Stable', 'Complications', and 'Death'. Compare two hypothetical drugs that alter transition probabilities.
How to Execute
1. Define the transition matrix based on published literature. 2. Use a package like `heemod` in R to build and run the cohort simulation over a 30-year horizon. 3. Calculate and compare the total costs and quality-adjusted life years (QALYs) for each drug. 4. Perform a one-way deterministic sensitivity analysis on a key parameter.
Intermediate
Project
Develop a Microsimulation for Screening Program Evaluation
Scenario
Evaluate the cost-effectiveness of a new cancer screening test. The model must track individual patient pathways, including false positives, diagnostic work-ups, and treatment, with heterogeneous risk based on age and genetics.
How to Execute
1. Structure the model with discrete events (e.g., 'screening event', 'diagnosis event') and patient-specific attributes. 2. Implement the simulation using an object-oriented approach in R or Python, running 100,000+ virtual patients. 3. Calibrate the model's incidence and sensitivity parameters to national registry data. 4. Report outcomes per 1,000 simulated individuals and conduct a PSA to generate a cost-effectiveness acceptability curve (CEAC).
Advanced
Project
Architect a Discrete Event Simulation for Hospital-Based Chronic Disease Management
Scenario
Model the patient flow for a congestive heart failure (CHF) clinic to assess the impact of a remote monitoring intervention on hospital readmissions, clinic capacity, and total payer costs.
How to Execute
1. Map the care pathway as a DES with entities (patients), resources (nurses, clinic slots), and queues (waitlist for clinic). 2. Parameterize the model using electronic health record data on arrival rates, service times, and readmission risks. 3. Build the model in specialized software (Arena, AnyLogic) or a programmatic DES library. 4. Validate the baseline model against current operational metrics. 5. Use the model to simulate the intervention, conducting scenario analysis on different staffing levels and monitoring thresholds to find the optimal operational strategy.
Tools & Frameworks
Software & Platforms
R (packages: `hesim`, `heemod`, `survival`, `simmer`)Python (packages: `simpy`, `mesa`, `numpy`)Arena / AnyLogic / TreeAgeExcel (for simple models and stakeholder communication)
R and Python offer maximum flexibility, scalability, and integration with statistical analysis for bespoke model development. Commercial software (Arena, AnyLogic) provides robust visualization and DES-specific features for complex operational models. Excel is used for initial prototyping and presenting models to non-technical audiences.
Statistical & Methodological Frameworks
Survival Analysis (parametric survival models, hazard functions)Cost-Effectiveness Analysis (CEA) & Cost-Utility Analysis (CUA)Probabilistic Sensitivity Analysis (PSA) and Value of Information (VOI)Model Calibration Techniques (e.g., likelihood-based, Bayesian)
Survival analysis provides the engine for time-to-event transitions. CEA/CUA frameworks define the output metrics (ICER, NMB). PSA and VOI are essential for quantifying uncertainty and informing evidence generation strategies. Calibration bridges the gap between model parameters and real-world data.
Interview Questions
Answer Strategy
The answer must demonstrate the ability to design a hybrid or complex model structure. Strategy: Propose a Markov or microsimulation model with multiple health states (e.g., 'Progression-Free without irAE', 'Progression-Free with managed irAE', 'Progressed Disease', 'Death'). Explain that transition probabilities to 'Progression-Free' states would be informed by trial Kaplan-Meier curves, with disutility and cost weights assigned to the 'irAE' state. A competing-risk framework or time-varying probabilities would model discontinuation. Emphasize the need for a half-cycle correction and PSA.
Answer Strategy
This tests validation skills, stakeholder management, and scientific integrity. Strategy: 1. Frame the answer by stating the model was built transparently. 2. Describe the systematic process used: you re-verified data sources, conducted extensive sensitivity analyses, and identified the specific model component (e.g., a transition probability) driving the counter-intuitive result. 3. Explain how you presented the findings back to the clinicians, showing the model output was mathematically consistent with the input assumptions, and used it as a collaborative tool to refine the clinical assumptions or gather new data, ultimately strengthening the model's validity.
Careers That Require Markov modeling, microsimulation, and discrete event simulation for disease progression